The drug "Galvus Met" is described by the instructions as a combined oral agent belonging to the pharmacological group of hypoglycemic drugs. Taking this medication allows you to effectively monitor blood glucose in people who suffer from diabetes mellitus twenty-four hours a day. At the same time, the Galvus Met combination drug (the instructions confirm) is based on an increase in the levels of HIP and GLP-1, an improvement in the so-called glucose-dependent insulin secretion, and an increase in pancreatic B cell glucose susceptibility. As for the features of absorption and excretion of this hypoglycemic agent, when it is taken on an empty stomach, the highest plasma concentrations begin to be noted after 1.7-2 hours, and the half-life is about 3-6 hours.

The medicine "Galvus Met" is produced in the form of oblong dragees of yellow-orange color. Each tablet contains fifty milligrams of vildagliptin, as well as metformin in the amount of five hundred, eight hundred and fifty or a thousand milligrams.
To take the hypoglycemic agent "Galvus Met", the instruction that comes with it is recommended exclusively for the purpose of treating type 2 diabetes mellitus in combination with physical exercises and special diet therapy. For example, doctors quite often prescribe this medicine to patients who have previously received metformin and vildagliptin in the form of single drugs. In case of insufficient effectiveness of use during treatment, only these substances are also advised to start taking Galvus Met tablets, instructions. The price of this tool is about 950 rubles, which means that many people can afford it.

The manufacturer categorically prohibits prescribing this combination drug to patients with established hypersensitivity to metformin or vildagliptin, as well as to all those who have any serious violations of the liver. People under the age of eighteen should likewise not start taking Galvus Met tablets. The instruction does not recommend taking them to patients who have an increased activity of liver enzymes. Among other things, this hypoglycemic drug is never prescribed for patients with lactase deficiency, myocardial infarction or galactose intolerance. The list of strict contraindications also includes conditions such as renal failure, chronic or acute forms of heart failure, respiratory failure, chronic alcoholism, metabolic acidosis, diabetic ketoacidosis, cardiovascular failure and pregnancy. This drug is not prescribed during lactation. In addition, this medicine is never taken two days before surgery, radiological and radioisotope medical studies, accompanied by the introduction of contrast agents.